<DOC>
	<DOCNO>NCT00725517</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety 7.5 % Icodextrin peritoneal dialysis solution once-daily long dwell exchange patient undergo Continuous Ambulatory Peritoneal Dialysis ( CAPD ) Chinese uremic patients.Patients divide Dianeal group Extraneal group long dwell time . Net ultrafiltration , small solute clearance relationship different transport group use evaluate efficacy Icodextrin . Physical examination , vital sign laboratory test use evaluate safety Icodextrin .</brief_summary>
	<brief_title>Efficacy Safety 7.5 % Icodextrin Peritoneal Dialysis Solution Once-Daily Long Dwell Exchange</brief_title>
	<detailed_description>A prospective , multicenter , randomize , double blind , parallel control study conduct 5 week 201 CAPD patient . These patient randomize 7 center 98 allocate Icodextrin group 103 Dextrose group . Before study , conventional glucose-based solution dialysate available China . Extraneal® one peritoneal dialysate produce Baxter contain 7.5 % Icodextrin . Patients involve study allocated Dianeal group Extraneal group randomize . In Dianeal group , prescription unchanged , Extraneal group , Extraneal dialysate use instead 2.5 % Dianeal . Assessments baseline , week 2 , week 4 include drain volume level glucose , creatinine , urea dialysate drain long dwell ; physical examination ; vital sign ; drain body weight ; laboratory analysis . Daily net peritoneal ultrafiltration , daily peritoneal creatine clearance daily peritoneal urea nitrogen clearance record prior 2 week , 4 week commence Extraneal .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Icodextrin</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>1 . Patients undergo continuous ambulatory peritoneal dialysis ( CAPD ) 90 day include study . 2 . Over age 18 3 . Received minimum 68 liter dialysis fluid per day nighttime must last 816 hour 2.5 % Dianeal® PD2 PD4 dialysate , dwell volume 2.0 liter 30 day screen visit 4 . No acute/chronic exit infection tunnel infection accompany peritonitis infection 30 day screen visit 1 . Be sensitive Icodextrin 2 . Suffer serious disease 3 . Attended invention research approve Ethics Committee 4 . Used drug trial 30 day screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Icodextrin</keyword>
	<keyword>ultrafiltration</keyword>
	<keyword>creatinine clearance</keyword>
	<keyword>urea nitrogen clearance</keyword>
</DOC>